As of 2026-06-01, the Fair Value of Esperion Therapeutics Inc (ESPR) is -0.39 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3.13 USD, the upside of Esperion Therapeutics Inc is -112.50%.
With the market price of 3.13 USD and our fair value calculation, Esperion Therapeutics Inc (ESPR) is not a good investment. Investing in ESPR stocks now will result in a potential loss of 112.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -269.10 | -233.70 | -209.25 | -51.75 | -22.68 | -157.30 |
| YoY growth | -87.40% | 13.15% | 10.46% | 75.27% | 56.17% | 13.53% |
| Market Cap (mil) | 803.82 |
| P/E | |
| Forward P/E |
| EPS | -0.03 |
| Avg earnings growth rate | 13.53% |
| TTM earnings | -7.42 |